Label Image (Lbl500905992)
Leflunomide Tablet, Film Coated
Product Images NDC 50090-5992
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 50090-5992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Leflunomide Fig1)
Percentage of ACR 20 responders at endpoint for Trial 1, Trial 2, and Trial 3 at different months with the use of Leflunomide, Methotrexate, Placebo, and Sulfasalazine. The rest of the text is not-available or unreadable.*
Figure2 (Leflunomide Fig2)
The text describes the percentage of responders over time for a trial with two different treatment groups (pPL-TF-MTX and A-LEF). The data is presented in a graph, where the x-axis represents time and the y-axis represents the percentage of responders. The analysis method used is "ACR Responders Observation Carried Forward".*
Figure3 (Leflunomide Fig3)
Figure4 (Leflunomide Fig4)
Structure (Leflunomide Str1)
Structure2 (Leflunomide Str2)
F3C and A77 1726 are potentially chemical compounds or medication names. Without additional information, it's difficult to provide a more specific and accurate description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
